Control of MyoD function during initiation of muscle differentiation by an autocrine signaling pathway activated by insulin-like growth factor-II - PubMed (original) (raw)
. 2006 Oct 6;281(40):29962-71.
doi: 10.1074/jbc.M605445200. Epub 2006 Aug 9.
Affiliations
- PMID: 16901893
- DOI: 10.1074/jbc.M605445200
Free article
Control of MyoD function during initiation of muscle differentiation by an autocrine signaling pathway activated by insulin-like growth factor-II
Elizabeth M Wilson et al. J Biol Chem. 2006.
Free article
Abstract
The insulin-like growth factors (IGFs) play key roles in muscle development, maintenance, and repair, but their mechanisms of action are incompletely defined. We previously identified an autocrine pathway involving production of IGF-II and activation of the IGF-I receptor, phosphatidylinositol 3-kinase, and Akt in myoblast differentiation induced by MyoD in 10T1/2 mesenchymal stem cells and found that blocking this pathway prevented differentiation (Wilson, E. M., Hsieh, M. M., and Rotwein, P. (2003) J. Biol. Chem. 278, 41109-41113). We now have analyzed regulation of MyoD function in this model system. Inhibition of IGF-II production impaired the transcriptional actions of MyoD, as seen by a 70-80% decline in activity of transfected reporter genes, including the myogenin and creatine kinase promoters, and by complete inhibition of transcription of the endogenous myogenin gene but had no effect on MyoD protein levels, post-translational modifications, or nuclear localization, and neither blocked the rapid disappearance of the inhibitory molecule Id1 nor altered the nuclear expression or abundance of the MyoD binding partner E12/E47. Impaired signaling through the IGF-I receptor also did not decrease the ability of MyoD or E12/E47 to bind to target DNA sites at the proximal myogenin promoter, as assessed by chromatin immunoprecipitation assay but, rather, blocked chromatin remodeling at this site, as indicated by reduced recruitment of co-activators p300 and P/CAF and diminished acetylation of histones H3 and H4. Taken together, these results show that IGF-II-initiated signaling through the insulin-like growth factor-I receptor targets transcriptional co-regulators that are essential co-factors for MyoD and suggests that the phosphatidylinositol 3-kinase-Akt pathway plays a key role in establishing an amplification cascade that is essential for sustaining the earliest events in muscle differentiation.
Similar articles
- Permissive roles of phosphatidyl inositol 3-kinase and Akt in skeletal myocyte maturation.
Wilson EM, Tureckova J, Rotwein P. Wilson EM, et al. Mol Biol Cell. 2004 Feb;15(2):497-505. doi: 10.1091/mbc.e03-05-0351. Epub 2003 Oct 31. Mol Biol Cell. 2004. PMID: 14595115 Free PMC article. - Autocrine growth factor signaling by insulin-like growth factor-II mediates MyoD-stimulated myocyte maturation.
Wilson EM, Hsieh MM, Rotwein P. Wilson EM, et al. J Biol Chem. 2003 Oct 17;278(42):41109-13. doi: 10.1074/jbc.C300299200. Epub 2003 Aug 25. J Biol Chem. 2003. PMID: 12941952 - Coordinate control of muscle cell survival by distinct insulin-like growth factor activated signaling pathways.
Lawlor MA, Rotwein P. Lawlor MA, et al. J Cell Biol. 2000 Dec 11;151(6):1131-40. doi: 10.1083/jcb.151.6.1131. J Cell Biol. 2000. PMID: 11121430 Free PMC article. - IGFs and muscle differentiation.
Florini JR, Ewton DZ, Magri KA, Mangiacapra FJ. Florini JR, et al. Adv Exp Med Biol. 1993;343:319-26. doi: 10.1007/978-1-4615-2988-0_31. Adv Exp Med Biol. 1993. PMID: 8184742 Review. - Growth hormone and the insulin-like growth factor system in myogenesis.
Florini JR, Ewton DZ, Coolican SA. Florini JR, et al. Endocr Rev. 1996 Oct;17(5):481-517. doi: 10.1210/edrv-17-5-481. Endocr Rev. 1996. PMID: 8897022 Review.
Cited by
- Distinct muscle regenerative capacity of human induced pluripotent stem cell-derived mesenchymal stromal cells in Ullrich congenital muscular dystrophy model mice.
Yokomizo-Goto M, Takenaka-Ninagawa N, Zhao C, Bourgeois Yoshioka CK, Miki M, Motoike S, Inada Y, Zujur D, Theoputra W, Jin Y, Toguchida J, Ikeya M, Sakurai H. Yokomizo-Goto M, et al. Stem Cell Res Ther. 2024 Oct 7;15(1):340. doi: 10.1186/s13287-024-03951-6. Stem Cell Res Ther. 2024. PMID: 39370505 Free PMC article. - Role of phosphatidylinositol 3,4,5-trisphosphate (PIP3) 5-phosphatase skeletal muscle- and kidney-enriched inositol polyphosphate phosphatase (SKIP) in myoblast differentiation.
Ijuin T, Takenawa T. Ijuin T, et al. J Biol Chem. 2012 Sep 7;287(37):31330-41. doi: 10.1074/jbc.M112.388785. Epub 2012 Jul 19. J Biol Chem. 2012. PMID: 22815484 Free PMC article. - Trpc1 ion channel modulates phosphatidylinositol 3-kinase/Akt pathway during myoblast differentiation and muscle regeneration.
Zanou N, Schakman O, Louis P, Ruegg UT, Dietrich A, Birnbaumer L, Gailly P. Zanou N, et al. J Biol Chem. 2012 Apr 27;287(18):14524-34. doi: 10.1074/jbc.M112.341784. Epub 2012 Mar 6. J Biol Chem. 2012. PMID: 22399301 Free PMC article. - Insulin-like growth factor-II in adipocyte regulation: depot-specific actions suggest a potential role limiting excess visceral adiposity.
Alfares MN, Perks CM, Hamilton-Shield JP, Holly JMP. Alfares MN, et al. Am J Physiol Endocrinol Metab. 2018 Dec 1;315(6):E1098-E1107. doi: 10.1152/ajpendo.00409.2017. Epub 2018 Jul 24. Am J Physiol Endocrinol Metab. 2018. PMID: 30040480 Free PMC article. - Gene expression during normal and FSHD myogenesis.
Tsumagari K, Chang SC, Lacey M, Baribault C, Chittur SV, Sowden J, Tawil R, Crawford GE, Ehrlich M. Tsumagari K, et al. BMC Med Genomics. 2011 Sep 27;4:67. doi: 10.1186/1755-8794-4-67. BMC Med Genomics. 2011. PMID: 21951698 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous